Page 69 - 《中国药房》2026年4期
P. 69

parenteral  nutrition  with  fluconazole[J].  Nutrition,2024,  [16]  LIM T P,HEE D K,LEE W,et al. Physicochemical stabi-
              123:112417.                                         lity study of polymyxin B in various infusion solutions for
          [ 3 ]  LIU Y G,LIAO M H,SANG X Q,et al. A case of precipi‐  administration to critically ill patients[J]. Ann Pharmaco‐
              tate  in  intravenous  line  when  general  anesthesia  imple‐  ther,2016,50(9):790-792.
              mented  with  remimazolam[J].  Heliyon,2022,8(12):  [17]  TSIOURIS M,ULMER M,YURCHO J F,et al. Stability
              e12491.                                             and  compatibility  of  reconstituted  caspofungin  in  select
          [ 4 ]  BRADLEY J S,WASSEL R T,LEE L,et al. Intravenous   elastomeric  infusion  devices[J].  Int  J  Pharm  Compd,
              ceftriaxone and calcium in the neonate:assessing the risk   2010,14(5):436-439.
              for  cardiopulmonary  adverse  events[J].  Pediatrics,2009,  [18]  CURTI C,SOUAB H K,LAMY E,et al. Stability studies
              123(4):e609-e613.                                   of  antipyocyanic  beta-lactam  antibiotics  used  in  continuous
          [ 5 ]  BARG N L,SUPENA R B,FEKETY R. Persistent staphy‐  infusion[J]. Pharmazie,2019,74(6):357-362.
              lococcal bacteremia in an intravenous drug abuser[J]. Anti‐  [19]  SORNSUVIT C,WIENTONG P,UITRAKUL S,et al. In‐
              microb Agents Chemother,1986,29(2):209-211.         fluence  of  concentration  and  temperature  on  stability  of
          [ 6 ]  MARSILIO N R,DA SILVA D,BUENO D. Drug incom‐     imipenem  focused  on  solutions  for  extended  infusion[J].
              patibilities in the adult intensive care unit of a university   Dose Response,2021,19(4):15593258211059325.
              hospital[J]. Rev Bras Ter Intensiva,2016,28(2):147-153.  [20]  郑晨,王钰,何晓静,等. 对头孢他啶注射液稳定性的影
          [ 7 ]  LESSARD J J,CARON E,SCHÉRER H,et al. Compa-      响因素研究[J]. 中国临床药理学杂志,2017,33(23):
              tibility  of  Y-site  injection  of  meropenem  trihydrate  with   2443-2445.
              101 other injectable drugs[J]. Hosp Pharm,2020,55(5):  [21]  CAVASSIN F B,BAÚ-CARNEIRO J L,VILAS-BOAS R
              332-337.                                            R,et al. Sixty years of amphotericin B:an overview of the
          [ 8 ]  Truven Health Analytics. Micromedex[DB/OL]. [2025-02-  main antifungal agent used to treat invasive fungal infec‐
              15]. https://www.micromedexsolutions.com.           tions[J]. Infect Dis Ther,2021,10(1):115-147.
          [ 9 ]  GIMÉNEZ-GINER  S,LLOPIS-ALEMANY  A,PORTA-   [22]  吕薛,胡立宏. 两性霉素B的结构修饰研究进展[J]. 药学
              OLTRA B,et al. Chemical stability and physical compa-  研究,2016,35(11):621-627.
              tibility  of  meropenem  in  admixtures  for  continuous  and   [23]  RAVERDY V,AMPE E,HECQ J D,et al. Stability and
              extended  intravenous  infusions[J].  Enferm  Infecc  Micro‐  compatibility  of  vancomycin  for  administration  by  con‐
              biol Clin(Engl Ed),2023,41(10):612-616.             tinuous  infusion[J].  J  Antimicrob  Chemother,2013,68
          [10]  KEEL R A,SUTHERLAND C A,CRANDON J L,et al.       (5):1179-1182.
              Stability of doripenem,imipenem and meropenem at ele-  [24]  MEYER  K,SANTAROSSA  M,DANZIGER  L  H,et  al.
              vated  room  temperatures[J].  Int  J  Antimicrob  Agents,  Compatibility  of  ceftazidime-avibactam, ceftolozane-
              2011,37(2):184-185.                                 tazobactam,and piperacillin-tazobactam with vancomycin
          [11]  MEHTA  S,ARMSTRONG  B  K,KIM  S  J,et  al.  Long-  in  dextrose  5%  in  water[J].  Hosp  Pharm,2017,52(3):
              term  potency,sterility,and  stability  of  vancomycin,cef‐  221-228.
              tazidime,and moxifloxacin for treatment of bacterial en‐  [25]  LEUNG  E,VENKATESAN  N,LY  S  C,et  al.  Physical
              dophthalmitis[J]. Retina,2011,31(7):1316-1322.      compatibility  of  vancomycin  and  piperacillin  sodium-
          [12]  WALKER S E,IAZZETTA J,LAW S,et al. Stability of   tazobactam  at  concentrations  typically  used  during  pro‐
              commonly used antibiotic solutions in an elastomeric infu‐  longed  infusions[J].  Am  J  Health  Syst  Pharm,2013,70
              sion device[J]. Can J Hosp Pharm,2010,63(3):212-224.  (13):1163-1166.
          [13]  DONNELLY R F. Stability of aseptically prepared tazocin   [26]  CONDIE  C  K,TYLER  L  S,BARKER  B,et  al.  Visual
              solutions  in  polyvinyl  chloride  bags[J].  Can  J  Hosp   compatibility of caspofungin acetate with commonly used
              Pharm,2009,62(3):226-231.                           drugs  during  simulated  Y-site  delivery[J].  Am  J  Health
          [14]  SAHRAOUI L,CHIADMI F,SCHLATTER J,et al. Sta‐      Syst Pharm,2008,65(5):454-457.
              bility  of  voriconazole  injection  in  0.9%  sodium  chloride   [27]  O’DONNELL J N,VENKATESAN N,MANEK M,et al.
              and 5% dextrose injections[J]. Am J Health Syst Pharm,  Visual and absorbance analyses of admixtures containing
              2006,63(15):1423-1426.                              vancomycin  and  piperacillin-tazobactam  at  commonly
          [15]  HE J,FIGUEROA D A,LIM T P,et al. Stability of poly‐  used concentrations[J]. Am J Health Syst Pharm,2016,73
              myxin B sulfate diluted in 0.9% sodium chloride injection   (4):241-246.
              and  stored  at  4  or  25  degrees  C[J].  Am  J  Health  Syst   (收稿日期:2025-08-15  修回日期:2026-01-22)
              Pharm,2010,67(14):1191-1194.                                                        (编辑:孙 冰)


          中国药房  2026年第37卷第4期                                                 China Pharmacy  2026 Vol. 37  No. 4    · 475 ·
   64   65   66   67   68   69   70   71   72   73   74